News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets
Mydecine Innovations Group
Doug Drysdale | CEO, Cybin Corp
Cybin Inc.
Miri Halperin Wernli | President, MindMed
Mind Medicine (MindMed)
AWAKN Life Sciences Launches Clinical Research Division with Prof. David Nutt & Dr. Ben Sessa Identifying Suitable Studies Across Europe & North America
Awakn Life Sciences
Mydecine Innovations Group Completes Acquisition of Neuropharm Inc.
Mydecine Innovations Group
Mydecine Innovations Group Would Like to Give Thanks to its Shareholders for Extending the Lockup on the Five Cent Placement for Another 120 Days
Mydecine Innovations Group
Havn Life Sciences Announces Filing of Final Prospectus and Conditional Approval for Listing on CSE
Havn Life
Dr. Matthew Johnson Joins AWAKN Life Sciences
Awakn Life Sciences
MagicMed Industries Closes Oversubscribed Private Placement for $1,642,880 with Mackie Research Capital Corporation
Enveric Biosciences
Nova Mentis Biotech Corp Signs Psilocybin Research Agreement with France-Based Physiogenex
Nova Mentis Life Science
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.